coformycin has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, K; Sougawa, M; Tanaka, Y; Yoshii, G | 1 |
| DeConti, R; Ginsburg, R; Steinmetz, JC | 1 |
2 other study(ies) available for coformycin and Adenocarcinoma
| Article | Year |
|---|---|
[Problems of antineoplastic effects by PLDR (potential lethal damage repair) inhibitor--pharmacokinetics].
Topics: Adenocarcinoma; Aged; Animals; Chromatography, High Pressure Liquid; Coformycin; Combined Modality Therapy; Drug Synergism; Female; Humans; Kinetics; Lung Neoplasms; Mice; Mice, Inbred BALB C; Pentostatin; Rabbits; Rats; Rats, Inbred F344; Ribonucleosides; Vidarabine | 1984 |
Hypersensitivity vasculitis associated with 2-deoxycoformycin and allopurinol therapy.
Topics: Adenocarcinoma; Aged; Allopurinol; Arteritis; Coformycin; Drug Hypersensitivity; Humans; Lung Neoplasms; Male; Necrosis; Pentostatin; Ribonucleosides | 1989 |